Analyst Ratings For NASDAQ:CTSO – Cytosorbents (NASDAQ:CTSO)

.

Some recent analyst ratings include

• 5/9/2018-HC Wainwright Reiterated Rating of Buy.
• 1/25/2018-B. Riley Reiterated Rating of Buy.
• 7/25/2017-Aegis Reiterated Rating of Buy.
• 10/4/2016-Brean Capital initiated coverage with a Buy rating.

Recent Insider Trading Activity For NASDAQ:CTSO – Cytosorbents (NASDAQ:CTSO)
NASDAQ:CTSO – Cytosorbents (NASDAQ:CTSO) has insider ownership of 6.90% and institutional ownership of 10.53%.

• On 4/17/2018 Kathleen P Bloch, CFO, sold 120 with an average share price of $8.25 per share and the total transaction amounting to $990.00.
• On 3/15/2018 Kathleen P Bloch, CFO, sold 11,176 with an average share price of $8.25 per share and the total transaction amounting to $92,202.00.
• On 3/13/2018 Kathleen P Bloch, CFO, sold 1,104 with an average share price of $8.25 per share and the total transaction amounting to $9,108.00.
• On 2/21/2018 Kathleen P Bloch, CFO, sold 10,000 with an average share price of $8.00 per share and the total transaction amounting to $80,000.00.
• On 1/12/2018 Kathleen P Bloch, CFO, sold 12,400 with an average share price of $7.75 per share and the total transaction amounting to $96,100.00.
• On 1/8/2018 Kathleen P Bloch, CFO, sold 32,400 with an average share price of $7.30 per share and the total transaction amounting to $236,520.00.
• On 11/27/2017 Vincent Capponi, COO, sold 4,000 with an average share price of $7.00 per share and the total transaction amounting to $28,000.00.

Recent Trading Activity for NASDAQ:CTSO – Cytosorbents (NASDAQ:CTSO)
Shares of NASDAQ:CTSO – Cytosorbents closed the previous trading session at 8.15 up +0.10 1.24% with 7.900000095367432 shares trading hands.